Advertisement

Loading...

VBI Vaccines Inc.

VBIV•NASDAQ
Healthcare
Biotechnology
$0.07
$-0.07(-50.87%)
U.S. Market is Open • 12:58

VBI Vaccines Inc. (VBIV) Stock Overview

Explore VBI Vaccines Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap1.9M
P/E Ratio-0.01
EPS (TTM)$-3.54
ROE-2.59%
Fundamental Analysis

AI Price Forecasts

1 MonthN/A
3 MonthsN/A
1 Year Target$0.00

VBIV Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of VBI Vaccines Inc. (VBIV) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

Our forecasting models predict significant price movements, with a 12-month target of $0.00.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -0.01 and a market capitalization of 1.9M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
N/A
5-Day Change
273.14%
1-Month Change
-50.87%
3-Month Change
-89.28%
6-Month Change
-89.03%
Year-to-Date (YTD) Change
-89.40%
1-Year Change
-94.65%
3-Year Change
-99.94%
5-Year Change
-99.62%
All-Time (Max) Change
-80.46%

Contact Information

https://www.vbivaccines.com
617 830 3031
160 Second Street, Cambridge, MA, 02142

Company Facts

1,310 Employees
IPO DateApr 26, 2010
CountryUS

Frequently Asked Questions